1. Home
  2. PUBM vs SGP Comparison

PUBM vs SGP Comparison

Compare PUBM & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PubMatic Inc.

PUBM

PubMatic Inc.

HOLD

Current Price

$16.39

Market Cap

747.5M

Sector

Technology

ML Signal

HOLD

Logo SpyGlass Pharma Inc. Common Stock

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$26.61

Market Cap

891.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PUBM
SGP
Founded
2006
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
747.5M
891.1M
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
PUBM
SGP
Price
$16.39
$26.61
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$12.43
$45.00
AVG Volume (30 Days)
804.1K
60.9K
Earning Date
05-07-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$282,926,000.00
N/A
Revenue This Year
$3.44
N/A
Revenue Next Year
$7.86
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.15
$17.06
52 Week High
$18.44
$30.56

Technical Indicators

Market Signals
Indicator
PUBM
SGP
Relative Strength Index (RSI) 56.30 58.91
Support Level $8.67 $24.87
Resistance Level $18.44 $27.53
Average True Range (ATR) 0.59 1.17
MACD -0.18 -0.18
Stochastic Oscillator 30.23 46.33

Price Performance

Historical Comparison
PUBM
SGP

About PUBM PubMatic Inc.

PubMatic Inc is is an independent, artificial intelligence-powered advertising technology company that delivers digital advertising performance. Its integrated technology platform connects buyers, publishers, data providers, and commerce media networks on a single, unified platform, to deliver advertising performance, control, transparency and efficiency. Its platform empowers the world's digital content creators (publishers) to maximize monetization of their advertising inventory and audiences and provides control and transparency to buyers, which includes advertisers, agencies, agency trading desks, and demand side platforms (DSPs) (referred as buyers). Geographically, the company generates the majority of its revenue from the United States, followed by EMEA, APAC, and Rest of the World.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: